无标签和无固定蛋白质结合测定通过紫外线短暂吸收显微镜
Jianghao Shen1, Qiangqiang Wang2, Fan Wu1
1Institute of Medical Photonics, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 27, 2026
概括
我们开发了紫外线短暂吸收显微镜 (UV-TAM) 用于无标签的蛋白质 - 连接体相互作用研究. 这种方法直接检测溶液中的结合,为药物发现提供了一个新的工具.
科学领域:
- 生物化学 生物化学
- 生物物理学的生物物理.
- 分析化学 分析化学
背景情况:
- 蛋白质-连接体相互作用对于生物过程和药物开发至关重要.
- 研究这些相互作用的传统方法通常需要标记或固定,这可能会干扰自然的结合行为.
研究的目的:
- 引入紫外线暂时吸收显微镜 (UV-TAM) 作为一种新的,无标签的技术,用于研究溶液中的蛋白质-联体相互作用.
- 为了证明UV-TAM对于实时检测约束事件和定量分析的实用性.
主要方法:
- 利用 femtosecond深紫外线激光脉冲来激发和近紫外线探针束来监测托残留激发状态动态的变化.
- 采用UV-TAM进行无标签的溶液测量,使用微升样本体积测量蛋白质 - 配体结合.
- 应用该技术来研究血蛋白 (牛血清白蛋白,血红蛋白) 和类连接物 (贝贝林,棕胺) 之间的相互作用.
主要成果:
- UV-TAM成功地通过对接体诱导的时间解析光谱动态变化检测了结合事件.
- 对血红蛋白-类化合物相互作用的定量分析提供了与通过异热定位热量计获得的密切匹配的解离常数.
- 证明了UV-TAM技术的无标签和溶液中的功能.
结论:
- UV-TAM提供了一个强大的,无校准的平台,用于直接检测和量化溶液中的蛋白质-连接体相互作用.
- 该技术显示了促进生物化学研究和促进高通量药物发现查的巨大潜力.
相关概念视频
Protein Absorption
981
Proteins in the gastrointestinal tract typically come from food, but they can also originate from disintegrated cells or secreted enzymes. In the stomach, the enzyme pepsin breaks down these proteins into polypeptides. The fragments then move into the duodenum as a semi-fluid mass called chyme. Pancreatic proteases, such as trypsin and chymotrypsin, and intestinal brush border enzymes like carboxypeptidases further dismantle the polypeptides into tripeptides, dipeptides, and free amino acids.
981
Factors Affecting Protein-Drug Binding: Protein-Related Factors
547
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
547
The Equilibrium Binding Constant and Binding Strength
15.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Protein-Drug Binding: Determination Methods
646
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
646
Drug Distribution: Plasma Protein Binding
8.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K
Protein-Drug Binding: Mechanism and Kinetics
1.8K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.8K


